The current price of 688575.SS is CN¥11.08 — it has decreased by 2.03% since the previous close. Data as of Nov 6, 2026.
688575.SS is up 1.84% over the past week, up 5.42% over the past month and down 26.33% over the past year. The price is below its 200-day moving average of CN¥11.55.
Of the 4 analysts covering Shenzhen YHLO Biotech Co., Ltd., 4 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Shenzhen YHLO Biotech Co., Ltd. has a market capitalization of CN¥6.33B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Shenzhen YHLO Biotech Co., Ltd. posted earnings of CN¥0.13 per share. Upcoming reports are listed in the earnings calendar.
Shenzhen YHLO Biotech Co., Ltd. reported revenue of CN¥541M in its most recent quarter, which has increased by 13.12% compared with the same quarter a year earlier. Analysts had expected CN¥540.79M.
Yes. Shenzhen YHLO Biotech Co., Ltd. pays dividends annually. The latest payment of CN¥0.021 per share has a payment date of Jun 12, 2026, which corresponds to a dividend yield of 0.22%.
In the latest trading session 688575.SS moved between CN¥10.91 and CN¥11.38, a range of 4.24% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Shenzhen YHLO Biotech Co., Ltd. shows a buy rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Shenzhen YHLO Biotech Co., Ltd. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 688575.SS has traded between CN¥8.34 and CN¥17.00. The current price is 34.82% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.